USA • New York Stock Exchange • NYSE:ELV • US0367521038
The current stock price of ELV is 345.74 USD. In the past month the price decreased by -1.37%. In the past year, price decreased by -12.63%.
ChartMill assigns a technical rating of 3 / 10 to ELV. When comparing the yearly performance of all stocks, ELV is a bad performer in the overall market: 68.13% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to ELV. There are concerns on the financial health of ELV while its profitability can be described as average.
Over the last trailing twelve months ELV reported a non-GAAP Earnings per Share(EPS) of 30.17. The EPS decreased by -8.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.84% | ||
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| Debt/Equity | 0.71 |
28 analysts have analysed ELV and the average price target is 398.1 USD. This implies a price increase of 15.14% is expected in the next year compared to the current price of 345.74.
For the next year, analysts expect an EPS growth of -9.74% and a revenue growth 3.31% for ELV
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 103,158 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
ELEVANCE HEALTH INC
220 Virginia Avenue
Indianapolis INDIANA US
Employees: 103158
Phone: 18003311476
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 103,158 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
The current stock price of ELV is 345.74 USD. The price decreased by -0.36% in the last trading session.
ELEVANCE HEALTH INC (ELV) has a dividend yield of 2.01%. The yearly dividend amount is currently 6.55.
ELV has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
28 analysts have analysed ELV and the average price target is 398.1 USD. This implies a price increase of 15.14% is expected in the next year compared to the current price of 345.74.
The PE ratio for ELEVANCE HEALTH INC (ELV) is 11.46. This is based on the reported non-GAAP earnings per share of 30.17 and the current share price of 345.74 USD.
The next ex-dividend date for ELEVANCE HEALTH INC (ELV) is December 5, 2025.